
Bempedoic acid: Uses, Dosage, Side Effects, Warnings - Drugs.com
Jul 25, 2024 · Bempedoic acid (brand name Nexletol) is an oral, non-statin, LDL cholesterol-lowering treatment that may be used in adults to: lower the risk of heart attack and heart procedures (for …
Bempedoic acid (oral route) - Side effects & dosage - Mayo Clinic
Feb 1, 2026 · Description Bempedoic acid is used together with diet and other cholesterol-lowering medicines to reduce bad cholesterol (LDL) in patients with primary hyperlipidemia (high blood …
Bempedoic Acid: A New Tool for LDL-Cholesterol Control in Patients …
Abstract Nowdays a small proportion of patients with high/very high/extreme atherosclerotic cardiovascular disease risk achieves the optimal target of LDL-cholesterol, because of drug …
NEXLETOL (Bempedoic Acid): Uses & Side Effects - Cleveland Clinic
NEXLETOL (bempedoic acid) lowers cholesterol in your blood. Cholesterol is a type of fat that helps your body perform many important functions.
Efficacy of Bempedoic Acid, Novel Treatment for Elevated LDL Cholesterol
Feb 17, 2025 · By Anthony Rice Bempedoic acid is a novel non-statin drug produced by Esperion Therapeutics to treat hypercholesterolemia, elevated levels of low-density lipoprotein (LDL) …
Bempedoic Acid: MedlinePlus Drug Information
Bempedoic acid is used together with lifestyle changes (diet, weight-loss, exercise) and certain cholesterol-lowering medications (HMG-CoA reductase inhibitors [statins]) to further decrease low …
- [PDF]
BEMPEDOIC ACID
BEMPEDOIC ACID What is bempedoic acid? eral medications can help lower low-density lipoprote cholesterol (LDL-C). The most commonly prescribed medications are statins. When patients have …
Bempedoic acid | Drugs | BNF | NICE
View bempedoic acid information, including dose, uses, side-effects, pregnancy, breast feeding and drug action.
Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant ...
Mar 4, 2023 · In several studies, bempedoic acid reduced the level of LDL cholesterol by 17 to 28%, a finding that, in 2020, prompted its approval by the Food and Drug Administration and the European …
Bempedoic acid: mechanism, evidence, safety, and guideline role in …
Dec 2, 2025 · Lowering low-density lipoprotein cholesterol remains foundational in reducing atherosclerotic cardiovascular disease. Statins, ezetimibe, and PCSK9 inhibitors have established …